These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6137430)

  • 1. Hyperglycemia and beta-cell adaptation during prolonged somatostatin infusion with glucagon replacement in man.
    Ward WK; Halter JB; Best JD; Beard JC; Porte D
    Diabetes; 1983 Oct; 32(10):943-7. PubMed ID: 6137430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged hyperglycaemia during infusion of glucose and somatostatin impairs pancreatic A- and B-cell responses to decrements in plasma glucose in normal man: evidence for induction of altered sensitivity to glucose.
    Dimitriadis G; Cryer P; Gerich J
    Diabetologia; 1985 Feb; 28(2):63-9. PubMed ID: 2858423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged infusion of somatostatin with glucagon replacement increases plasma glucose and glucose turnover in man.
    Ward WK; Best JD; Halter JB; Porte D
    J Clin Endocrinol Metab; 1984 Mar; 58(3):449-53. PubMed ID: 6141177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory action of somatostatin on pancreatic alpha and beta cell function.
    Leblanc H; Anderson JR; Sigel MB; Yen SS
    J Clin Endocrinol Metab; 1975 Apr; 40(4):568-72. PubMed ID: 1092707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatin blockade of acute and chronic stimuli of the endocrine pancreas and the consequences of this blockade on glucose homeostasis.
    Chideckel EW; Palmer J; Koerker DJ; Ensinck J; Davidson MB; Goodner CJ
    J Clin Invest; 1975 Apr; 55(4):754-62. PubMed ID: 804491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of glucagon replacement on the hyperglycemic and hyperketonemic response to prolonged somatostatin infusion in normal man.
    Sherwin RS; Tamborlane W; Hendler R; Saccá L; DeFronzo RA; Felig P
    J Clin Endocrinol Metab; 1977 Nov; 45(5):1104-7. PubMed ID: 925134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra-islet insulin permits glucose to directly suppress pancreatic A cell function.
    Greenbaum CJ; Havel PJ; Taborsky GJ; Klaff LJ
    J Clin Invest; 1991 Sep; 88(3):767-73. PubMed ID: 1679440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous hyperglycemia restores insulin release impaired by somatostatin analogue.
    Taborsky GJ; Porte D
    Am J Physiol; 1981 Apr; 240(4):E407-13. PubMed ID: 6111928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normalization of insulin responses to glucose by overnight infusion of glucagon-like peptide 1 (7-36) amide in patients with NIDDM.
    Rachman J; Gribble FM; Barrow BA; Levy JC; Buchanan KD; Turner RC
    Diabetes; 1996 Nov; 45(11):1524-30. PubMed ID: 8866556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restoration of stable metabolic conditions during islet suppression in dogs.
    Bradley DC; Bergman RN
    Am J Physiol; 1992 Apr; 262(4 Pt 1):E532-8. PubMed ID: 1348903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose homeostasis during prolonged suppression of glucagon and insulin secretion by somatostatin.
    Sherwin RS; Hendler R; DeFronzo R; Wahren J; Felic P
    Proc Natl Acad Sci U S A; 1977 Jan; 74(1):348-52. PubMed ID: 264686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic somatostatin is a mediator of glucagon inhibition by hyperglycemia.
    Klaff LJ; Taborsky GJ
    Diabetes; 1987 May; 36(5):592-6. PubMed ID: 2883057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intermittent endogenous hyperglucagonemia on glucose homeostasis in normal and diabetic man.
    Rizza R; Verdonk C; Miles J; Service FJ; Gerich J
    J Clin Invest; 1979 Jun; 63(6):1119-23. PubMed ID: 447838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
    Rizza RA; Cryer PE; Gerich JE
    J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of loss of first-phase insulin secretion on hepatic glucose production and tissue glucose disposal in humans.
    Luzi L; DeFronzo RA
    Am J Physiol; 1989 Aug; 257(2 Pt 1):E241-6. PubMed ID: 2669517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of somatostatin and a glucagon-specific analog on glucose homeostasis during arginine infusion.
    Lien EL
    Metabolism; 1978 Sep; 27(9):1095-100. PubMed ID: 682972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The glucoregulatory response to intravenous glucose infusion in normal man: roles of insulin and glucose.
    Saccà L; Vitale D; Cicala M; Trimarco B; Ungaro B
    Metabolism; 1981 May; 30(5):457-61. PubMed ID: 6112655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimal increases in glucagon levels enhance glucose production in man with partial hypoinsulinemia.
    Lins PE; Wajngot A; Adamson U; Vranic M; Efendić S
    Diabetes; 1983 Jul; 32(7):633-6. PubMed ID: 6134650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of insulin on fasting and meal-stimulated somatostatin-like immunoreactivity in noninsulin-dependent diabetes mellitus: evidence for more than one mechanism of action.
    Gutniak M; Grill V; Efendić S
    J Clin Endocrinol Metab; 1986 Jan; 62(1):77-83. PubMed ID: 2866196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperglycemia per se (insulin and glucagon withdrawn) can inhibit hepatic glucose production in man.
    Liljenquist JE; Mueller GL; Cherrington AD; Perry JM; Rabinowitz D
    J Clin Endocrinol Metab; 1979 Jan; 48(1):171-5. PubMed ID: 422700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.